| abstract |
The invention relates to cell preparations comprising dendritic cell (DC) sub- populations, methods of obtaining such cell preparations, and the use of such preparations for improved immune and cancer therapy. More specifically, embodiments of the invention relate to the production and use of substantially pure human DC subpopulations, useful in the preparation of vaccines against inflammatory diseases and cancer, as well as cell preparations for eliciting immuno- tolerance. |